WELLS FARGO & COMPANY/MN - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,070
-72.7%
11,280
-33.9%
0.00%
Q2 2023$44,196
+34.7%
17,064
+112.2%
0.00%
Q1 2023$32,815
+553.7%
8,043
+704.3%
0.00%
Q4 2022$5,020
-73.6%
1,000
-31.5%
0.00%
Q3 2022$19,000
-20.8%
1,459
-21.3%
0.00%
Q2 2022$24,000
-87.6%
1,853
-85.4%
0.00%
Q1 2022$193,000
-42.2%
12,672
-32.6%
0.00%
Q4 2021$334,000
-13.0%
18,815
+2.9%
0.00%
Q3 2021$384,000
-55.0%
18,292
-57.8%
0.00%
Q2 2021$854,000
+85.7%
43,332
+174.2%
0.00%
Q1 2021$460,000
-57.8%
15,801
-56.1%
0.00%
Q4 2020$1,090,000
+34.1%
35,978
-29.6%
0.00%
Q3 2020$813,000
-50.8%
51,113
-39.0%
0.00%
Q2 2020$1,654,000
+261.1%
83,792
+125.7%
0.00%
Q1 2020$458,000
-2.3%
37,131
+46.5%
0.00%
Q4 2019$469,000
+897.9%
25,337
+640.8%
0.00%
Q3 2019$47,000
+4600.0%
3,420
+6740.0%
0.00%
Q2 2019$1,000500.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$237,228,00052.50%
Ponoi II Management, LLC 1,298,908$16,990,00044.41%
Ponoi Management, LLC 1,298,908$16,990,00023.20%
Euclidean Capital LLC 746,674$9,766,0009.07%
StepStone Group LP 1,573,357$20,580,0002.93%
Logos Global Management LP 850,000$11,118,0001.37%
First Light Asset Management, LLC 955,505$12,498,0001.26%
GREAT POINT PARTNERS LLC 316,256$4,137,0001.00%
Rubric Capital Management LP 877,161$11,473,0000.58%
Avidity Partners Management LP 1,798,100$23,519,0000.48%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders